Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes: Results of the Prospective Population-Based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study
Joachim Spranger,Anja Kroke,Matthias Möhlig,Kurt Hoffmann,Manuela M. Bergmann,Michael Ristow,Heiner Boeing,Andreas Pfeiffer +7 more
TL;DR: The data suggest that the pattern of circulating inflammatory cytokines modifies the risk for type 2 diabetes, and strongly support the hypothesis that a subclinical inflammatory reaction has a role in the pathogenesis of type 2abetes.
read more
Abstract: A subclinical inflammatory reaction has been shown to precede the onset of type 2 (non-insulin-dependent) diabetes. We therefore examined prospectively the effects of the central inflammatory cytokines interleukin (IL)-1beta, IL-6, and tumor necrosis factor-alpha (TNF-alpha) on the development of type 2 diabetes. We designed a nested case-control study within the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study including 27,548 individuals. Case subjects were defined to be those who were free of type 2 diabetes at baseline and subsequently developed type 2 diabetes during a 2.3-year follow-up period. A total of 192 cases of incident type 2 diabetes were identified and matched with 384 non-disease-developing control subjects. IL-6 and TNF-alpha levels were found to be elevated in participants with incident type 2 diabetes, whereas IL-1beta plasma levels did not differ between the groups. Analysis of single cytokines revealed IL-6 as an independent predictor of type 2 diabetes after adjustment for age, sex, BMI, waist-to-hip ratio (WHR), sports, smoking status, educational attainment, alcohol consumption, and HbA(1c) (4th vs. the 1st quartile: odds ratio [OR] 2.6, 95% CI 1.2-5.5). The association between TNF-alpha and future type 2 diabetes was no longer significant after adjustment for BMI or WHR. Interestingly, combined analysis of the cytokines revealed a significant interaction between IL-1beta and IL-6. In the fully adjusted model, participants with detectable levels of IL-1beta and elevated levels of IL-6 had an independently increased risk to develop type 2 diabetes (3.3, 1.7-6.8), whereas individuals with increased concentrations of IL-6 but undetectable levels of IL-1beta had no significantly increased risk, both compared with the low-level reference group. These results were confirmed in an analysis including only individuals with HbA(1c) <5.8% at baseline. Our data suggest that the pattern of circulating inflammatory cytokines modifies the risk for type 2 diabetes. In particular, a combined elevation of IL-1beta and IL-6, rather than the isolated elevation of IL-6 alone, independently increases the risk of type 2 diabetes. These data strongly support the hypothesis that a subclinical inflammatory reaction has a role in the pathogenesis of type 2 diabetes.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Decreased Circulating Levels of APRIL: Questioning Its Role in Diabetes
Adriana Carvalho-Santos,Marcelo Ribeiro-Alves,Luciene Carvalho Cardoso-Weide,Joyce Nunes,Lia Rafaella Ballard Kuhnert,Analúcia Rampazzo Xavier,Samuel Cunha,Michael Hahne,Déa Maria Serra Villa-Verde,Carla E. Carvalho-Pinto +9 more
TL;DR: The decrease of serum APRIL levels in diabetic patients suggests that this cytokine has a role in T1D and T2D, and suggests that APRIL can be considered as a potential modulating cytokine in the inflammatory process of diabetes.
Improving the Effect of Ferulic Acid on Inflammation and Insulin Resistance by Regulating the JNK/ERK and NF-κB Pathways in TNF-α-Treated 3T3-L1 Adipocytes
Jae-Eun Park,Ji-Sook Han +1 more
TL;DR: Findings indicate that ferulic acid can improve inflammation and insulin resistance in adipocytes by reducing inflammatory cytokine secretion by regulating JNK, ERK, and NF-κB and improved insulin resistance by suppressing pIRS-1ser.
8
Antioxidant, Anti-Inflammatory, Anti-Diabetic, and Pro-Osteogenic Activities of Polyphenols for the Treatment of Two Different Chronic Diseases: Type 2 Diabetes Mellitus and Osteoporosis
Emanuele Salvatore Scarpa,A. Antonelli,Giancarlo Balercia,Sofia Sabatelli,Filippo Maggi,Giovanni Caprioli,Gilberta Giacchetti,Matteo Micucci +7 more
TL;DR: This review describes the polyphenols that can exert protective effects against T2DM and osteoporosis through the modulation of specific molecular markers and pathways and could be used as adjuvants, in combination with synthetic drugs, in the future.
8
•Dissertation
The Impact of Diet on Immunosenescence
Sarah Jayne Clements
- 01 Apr 2017
TL;DR: The MED-diet showed potential to impact on the ageing immune cells investigated and could provide an economical approach to address problems associated with the ageing population.
8
References
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Cem Gabay,Irving Kushner +1 more
TL;DR: A large number of changes, distant from the site or sites of inflammation and involving many organ systems, may accompany inflammation, and the mechanisms mediating them are becoming better understood.
6.8K
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
TL;DR: Elevated levels of CRP and IL-6 predict the development of type 2 DM, and data support a possible role for inflammation in diabetogenesis.
4.6K
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women.
Frank B. Hu,JoAnn E. Manson,Meir J. Stampfer,Graham A. Colditz,Simin Liu,Caren G. Solomon,Walter C. Willett +6 more
TL;DR: The hypothesis that the majority of cases of type 2 diabetes could be prevented by the adoption of a healthier lifestyle is supported.
Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ
Minsheng Yuan,Nicky Konstantopoulos,Jongsoon Lee,Lone Hansen,Zhi-Wei Li,Michael Karin,Steven E. Shoelson +6 more
TL;DR: It is shown that high doses of salicylates reverse hyperglycemia, hyperinsulinemia, and dyslipidemia in obese rodents by sensitizing insulin signaling and identifies the IKKβ pathway as a target for insulin sensitization.
2K
NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.
TL;DR: NIDDM is associated with an elevated acute-phase response, particularly in those with features of syndrome X, and abnormalities of the innate immune system may be a contributor to the hypertriglyceridaemia, low HDL cholesterol, hypertension, glucose intolerance, insulin resistance and accelerated atherosclerosis of NIDDM.